Past decline versus current EGFR and subsequent mortality risk

Journal of the American Society of Nephrology

Volumn 27, Issue 8, 2016, Pages 2456-2466

  Naimark, David M J ^a   Grams, Morgan E ^b,c   Matsushita, Kunihiro ^b   Black, Corri ^d   Drion, Iefke ^e   Fox, Caroline S ^f,g   Inker, Lesley A ^h   Ishani, Areef ⁱ   Jee, Sun Ha ^j   Kitamura, Akihiko ^k   Lea, Janice P ^l   Nally, Joseph ^m   Peralta, Carmen Alicia ⁿ   Rothenbacher, Dietrich ^o,p   Ryu, Seungho ^q   Tonelli, Marcello ^r   Yatsuya, Hiroshi ^s   Coresh, Josef ^b   Gansevoort, Ron T ^t   Warnock, David G ^u   Woodward, Mark ^b,v,w   De Jong, Paul E ^t   more..

^a UNIVERSITY OF TORONTO   (Canada)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ABERDEEN   (United Kingdom)

^e ISALA HOSPITAL   (Netherlands)

^f FRAMINGHAM HEART STUDY   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h TUFTS MEDICAL CENTER   (United States)

ⁱ Minneapolis Veterans Affairs Health Care System   (United States)

^j Yonsei University   (South Korea)

^k Osaka Center for Cancer and Cardiovascular Diseases Prevention   (Japan)

^l EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m LERNER RESEARCH INSTITUTE   (United States)

ⁿ SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^o GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^p UNIVERSITY OF ULM   (Germany)

^q Sungkyunkwan University School of Medicine   (South Korea)

^r UNIVERSITY OF CALGARY   (Canada)

^s FUJITA HEALTH UNIVERSITY   (Japan)

^t UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^u UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^v UNIVERSITY OF OXFORD   (United Kingdom)

^w UNIVERSITY OF SYDNEY   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CREATININE; GLUCOSE; HEMOGLOBIN A1C;

ADULT; ALBUMINURIA; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DETERIORATION; DIABETES MELLITUS; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; FOLLOW UP; HUMAN; KIDNEY FUNCTION; MALE; MORTALITY RISK; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; AGED; CAUSE OF DEATH; COMPARATIVE STUDY; GLOMERULUS FILTRATION RATE; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; TIME FACTOR;

AGED; CAUSE OF DEATH; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TIME FACTORS;

EID: 85016432507     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015060688     Document Type: Article

References (29)

1. Kidney Disease: Improving Global Outcomes (KDiGO) CKD Work Group: KDiGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 3: 1-150, 2013
2. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, LameireN, Eknoyan G: Chronic kidney disease as a global public health problem: Approaches and initiatives-a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 72: 247-259, 2007
3. van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, de Jong P, Gansevoort RT, van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey AS, de Jong PE, Gansevoort RT, Levey A, El-NahasM, Eckardt KU, Kasiske BL, Ninomiya T, Chalmers J, Macmahon S, Tonelli M, Hemmelgarn B, Sacks F, Curhan G, Collins AJ, Li S, Chen SC, Hawaii Cohort KP, Lee BJ, Ishani A, Neaton J, Svendsen K,Mann JF, Yusuf S, Teo KK,Gao P,Nelson RG, KnowlerWC, Bilo HJ, Joosten H, Kleefstra N, Groenier KH, Auguste P, Veldhuis K, Wang Y, Camarata L, Thomas B, Manley T; Chronic Kidney Disease Prognosis Consortium: Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborativemeta-analysis of high-risk population cohorts. Kidney Int 79: 1341-1352, 2011
4. Gansevoort RT,Matsushita K, van der VeldeM, Astor BC,WoodwardM, Levey AS, de Jong PE, Coresh J; Chronic Kidney Disease Prognosis Consortium: Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 80: 93-104, 2011
5. Astor BC,Matsushita K,Gansevoort RT, van der VeldeM,WoodwardM, Levey AS, Jong PE, Coresh J, Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, de Jong PE, Coresh J, El-Nahas M, Eckardt KU, Kasiske BL, Wright J, Appel L, Greene T, Levin A, Djurdjev O, Wheeler DC, Landray MJ, Townend JN, Emberson J, Clark LE, Macleod A, Marks A, Ali T, Fluck N, Prescott G, Smith DH, Weinstein JR, Johnson ES, Thorp ML, Wetzels JF, Blankestijn PJ, van Zuilen AD, Menon V, Sarnak M, Beck G, Kronenberg F, Kollerits B, Froissart M, Stengel B,Metzger M, Remuzzi G, Ruggenenti P, Perna A, Heerspink HJ, Brenner B, de Zeeuw D, Rossing P, Parving HH, Auguste P, Veldhuis K, Wang Y, Camarata L, Thomas B, Manley T; Chronic Kidney Disease Prognosis Consortium: Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 79: 1331-1340, 2011
6. Cheng TY, Wen SF, Astor BC, Tao XG, Samet JM, Wen CP: Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan. AmJ KidneyDis 52: 1051-1060, 2008
7. Foley RN,MurrayAM, Li S,Herzog CA,McBeanAM, Eggers PW,Collins AJ: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 16: 489-495, 2005
8. Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT; Chronic Kidney Disease Prognosis Consortium: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 375: 2073-2081, 2010
9. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, HammLL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, SpinosaDJ, Wilson PW; American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention: Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108: 2154-2169, 2003
10. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164: 659-663, 2004
11. Turin TC, Coresh J, Tonelli M, Stevens PE, de Jong PE, Farmer CK, Matsushita K, Hemmelgarn BR: One-year change in kidney function is associated with an increasedmortality risk. AmJNephrol 36: 41-49, 2012
12. Turin TC, Coresh J, Tonelli M, Stevens PE, de Jong PE, Farmer CK, Matsushita K, Hemmelgarn BR: Change in the estimated glomerular filtration rate over time and risk of all-cause mortality. Kidney Int 83: 684-691, 2013
13. Al-Aly Z, Zeringue A, Fu J, Rauchman MI, McDonald JR, El-Achkar TM, Balasubramanian S, Nurutdinova D, Xian H, Stroupe K, Abbott KC, Eisen S: Rate of kidney function decline associates with mortality. J Am Soc Nephrol 21: 1961-1969, 2010
14. Perkins RM, Bucaloiu ID, Kirchner HL, Ashouian N, Hartle JE, Yahya T: GFR decline and mortality risk among patients with chronic kidney disease. Clin J Am Soc Nephrol 6: 1879-1886, 2011
15. Matsushita K, Selvin E, Bash LD, Franceschini N, Astor BC, Coresh J: Change in estimated GFR associates with coronary heart disease and mortality. J Am Soc Nephrol 20: 2617-2624, 2009
16. Rifkin DE, Shlipak MG, Katz R, Fried LF, Siscovick D, Chonchol M, Newman AB, Sarnak MJ: Rapid kidney function decline and mortality risk in older adults. Arch Intern Med 168: 2212-2218, 2008
17. Fox CS, Matsushita K, Woodward M, Bilo HJG, Chalmers J, Heerspink HJL, Lee BJ, Perkins RM, Rossing P, Sairenchi T, Tonelli M, Vassalotti JA, Yamagishi K, Coresh J, de Jong PE, Wen C-P, Nelson RG; Chronic Kidney Disease Prognosis Consortium: Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: A meta-analysis. Lancet 380: 1662-1673, 2012
18. Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, Polkinghorne KR, Shankar A, Smith DH, Tonelli M, Warnock DG, Wen CP, Coresh J, Gansevoort RT, Hemmelgarn BR, Levey AS; Chronic Kidney Disease Prognosis Consortium: Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 307: 1941-1951, 2012
19. Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, SarnakMJ, Astor BC, Coresh J, Levey AS, Gansevoort RT; CKD Prognosis Consortium: Cystatin C versus creatinine in determining risk based on kidney function. NEngl J Med369: 932-943, 2013
20. Coresh J, Turin TC,Matsushita K, Sang Y, BallewSH, Appel LJ, Arima H, Chadban SJ, CirilloM, DjurdjevO,Green JA, HeineGH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS; CKD Prognosis Consortium: Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 311: 2518-2531, 2014
21. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998
22. de Boer IH, Sun W, Cleary PA, Lachin JM, Molitch ME, Steffes MW, Zinman B; DCCT/EDiC Research Group: Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes. N Engl J Med 365: 2366-2376, 2011
23. Sud M, Tangri N, Pintilie M, Levey AS, Naimark DM: ESRD and death after heart failure in CKD. J Am Soc Nephrol 26: 715-722, 2015
24. Sud M, Tangri N, Pintilie M, Levey AS, Naimark D: Risk of end-stage renal disease and death after cardiovascular events in chronic kidney disease. Circulation 130: 458-465, 2014
25. Perkins RM, Tang X, Bengier AC, Kirchner HL, Bucaloiu ID: Variability in estimated glomerular filtration rate is an independent risk factor for death among patients with stage 3 chronic kidney disease. Kidney Int 82: 1332-1338, 2012
26. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604-612, 2009
27. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F; Chronic Kidney Disease Epidemiology Collaboration: Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serumcreatinine values. Clin Chem 53: 766-772, 2007
28. Kidney Disease Improving Global Outcomes (KDiGO) Work Group: KDiGO Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Chapter 2: Definition, identification, and prediction of CKD progression. Kidney Int Suppl 3: 63-72, 2013
29. MillerWG, Bruns DE, Hortin GL, Sandberg S, Aakre KM,McQueen MJ, Itoh Y, Lieske JC, SeccombeDW, JonesG, BunkDM,CurhanGC,Narva AS; National Kidney Disease Education Program-IFCC Working Group on Standardization of Albumin in Urine: Current issues inmeasurement and reporting of urinary albumin excretion. Clin Chem55: 24-38, 2009